Hindson Benjamin J. 4
4 · 10x Genomics, Inc. · Filed Dec 29, 2023
Insider Transaction Report
Form 4
Hindson Benjamin J.
DirectorSee Remarks
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2023-12-28−8,334→ 14,978 totalExercise: $11.48Exp: 2029-05-10→ Class A Common Stock (8,334 underlying) - Exercise/Conversion
Class A Common Stock
2023-12-28$11.48/sh+8,334$95,674→ 285,672 total
Footnotes (1)
- [F1]All of the shares subject to the option are fully vested and exercisable as of the date hereof.